Clinical Response with Sunitinib Therapy in the Treatment of Anaplastic Thyroid Cancer

Journals Menu

Follow SCIRP

	+1 323-425-8868
	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Journal of Cancer Therapy

ISSN Print: 2151-1934
ISSN Online: 2151-1942
www.scirp.org/journal/jct
E-mail: jct@scirp.org

Citations

Journals Menu

"Clinical Response with Sunitinib Therapy in the Treatment of Anaplastic Thyroid Cancer"
written by Kenneth M. Wong, Theodore Scott Nowicki, Carmelo Puccio, Tauseef Ahmed, Raj Tiwari, Jan Geliebter, Augustine Moscatello,
published by Journal of Cancer Therapy, Vol.3 No.2, 2012

has been cited by the following article(s):

Google Scholar
CrossRef

[1]	Stop Developing Drugs for the Cancer That Killed My Mother Funding drug development for rare cancers can hurt patients.
	2014

[2]	PHARMACOLOGIA. COM: Trusted? Authoritative? Significant Source of Information
	A Kulhari, A Sheorayan, A Chaudhury - pharmacologia.com, 2013

[3]	Experimental in vitro and in vivo Efficacy Assessment of Safironil as an Antifibrotic Therapy Potentially Enhance Reversal of Liver Fibrosis with Praziquantel Combination in Murine Chronic Schistosomiasis Mansoni
	Pharmacologia, 2012

Follow SCIRP

	+1 323-425-8868
	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Journal of Cancer Therapy

Journal of Cancer Therapy

Journals Menu

Home

About SCIRP

Service

Policies

[1]	Targeted Chemotherapeutics: An Overview of the Recent Progress in Effectual Cancer Treatment Pharmacologia, 2013 DOI:10.5567/pharmacologia.2013.535.552